Oncology & Cancer

Targeted therapies offer hope against aggressive cancer

Several new targeted therapies have shown promise against advanced cancers of the blood, lungs, ovaries, and thyroid, according to research released Saturday at a major US cancer conference.

Medications

Monthly birth control pill could replace daily doses

Oral contraceptives are one of the most popular forms of birth control: In the United States, about 12 percent of women between 15 and 49 use them. However, their effectiveness depends on being taken every day, and it is ...

Diseases, Conditions, Syndromes

Pfizer starts large trial for anti-COVID pill

Pfizer said Monday it had begun a middle-to-late stage clinical trial of a pill to stave off COVID in people who are exposed to infection.

HIV & AIDS

Naltrexone implant helps HIV patients prevent opioid relapse

(HealthDay)—Slow-release implantable naltrexone is associated with better outcomes than the oral drug for HIV-positive patients with an opioid addiction, according to a study published in the April issue of The Lancet HIV.

Medications

Drug trial shows promise for easing uterine fibroids

About three quarters of women will experience uterine fibroids before they reach the age of 50. With a range of often debilitating symptoms including excessive menstrual bleeding, they are the most common reason women undergo ...

page 2 from 12